Telmisartan and Heparin-induced thrombocytopenia test positive - a phase IV clinical study of FDA data

Summary:

Heparin-induced thrombocytopenia test positive is reported only by a few people who take Telmisartan.

The phase IV clinical study analyzes which people take Telmisartan and have Heparin-induced thrombocytopenia test positive. It is created by eHealthMe based on reports of 3,932 people who have side effects while taking Telmisartan from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

3,932 people reported to have side effects when taking Telmisartan.
Among them, 2 people (0.05%) have Heparin-induced thrombocytopenia test positive.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 4,365 Telmisartan users for its effectiveness, alternative drugs and more.

What is Heparin-induced thrombocytopenia test positive?

Heparin-induced thrombocytopenia test positive is found to be associated with 73 drugs and 26 conditions by eHealthMe.

Number of Telmisartan and Heparin-induced thrombocytopenia test positive reports submitted per year:

Could Telmisartan cause Heparin-induced thrombocytopenia test positive?

Gender of people who have Heparin-induced thrombocytopenia test positive when taking Telmisartan *:

female: 0.0 %
male: 100 %

Age of people who have Heparin-induced thrombocytopenia test positive when taking Telmisartan *:

Common drugs people take besides Telmisartan *:

Pantoprazole: 2 people, 100.00%
Clopidogrel: 2 people, 100.00%
Aspirin: 2 people, 100.00%

Common side effects people have besides Heparin-induced thrombocytopenia test positive *:

Troponin T Increased: 2 people, 100.00%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 100.00%
Presyncope: 2 people, 100.00%
International Normalised Ratio Increased: 2 people, 100.00%
Fibrin D Dimer Increased: 2 people, 100.00%
Electrocardiogram T Wave Inversion: 2 people, 100.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 100.00%
Coughing Up Blood: 2 people, 100.00%
Breathing Difficulty: 2 people, 100.00%
Back Pain: 2 people, 100.00%

Common conditions people have *:

Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Telmisartan and have Heparin-induced thrombocytopenia test positive?

Check whether Heparin-induced thrombocytopenia test positive is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .

Related studies

How severe was Heparin-induced thrombocytopenia test positive and when was it recovered:

Heparin-induced thrombocytopenia test positive in Telmisartan

Expand to all the drugs that have ingredients of telmisartan:

Heparin-induced thrombocytopenia test positive and drugs with ingredients of telmisartan

Alternative drugs to, pros and cons of Telmisartan:

Telmisartan (4,365 reports)

Common Telmisartan side effects:

High blood pressure: 422 reports
Fatigue (feeling of tiredness): 314 reports
Diarrhea: 275 reports
Drug ineffective: 253 reports
Breathing difficulty: 239 reports
Weakness: 231 reports
Dizziness: 228 reports
Headache (pain in head): 216 reports

Browse all side effects of Telmisartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Heparin-induced thrombocytopenia test positive treatments and more:

Heparin-induced thrombocytopenia test positive (79 reports)

COVID vaccines that are related to Heparin-induced thrombocytopenia test positive:

All the drugs that are associated with Heparin-induced thrombocytopenia test positive:

Heparin-induced thrombocytopenia test positive (73 drugs)

All the conditions that are associated with Heparin-induced thrombocytopenia test positive:

Heparin-induced thrombocytopenia test positive (26 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan (the active ingredients of Telmisartan) and Telmisartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.